InsiderTrades

Form 4 for DXCM Dexcom

Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001093557-23-000140 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2023-05-22 2023-05-18 DXCM Collins Richard Alexander Dir A - Grant $0.00 +2,906 6,854 +74% $0
I 2023-05-22 2023-05-18 DXCM Collins Richard Alexander Dir G - Gift $0.00 +3,948 36.4K +12% $0
2023-05-22 2023-05-18 DXCM Collins Richard Alexander Dir G - Gift $0.00 -3,948 2,906 -58% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-18 A A 2,906 $0.00 6,854 D by Trust — — (F1) The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
2 Common Common Stock 2023-05-18 G A 3,948 $0.00 36,404 I — — (F2) Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. (F3) Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee.
3 Common Common Stock 2023-05-18 G D 3,948 $0.00 2,906 D — — (F2) Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units.